Peiguang Zhang
Overview
Explore the profile of Peiguang Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang P, Cao J, Liang X, Su Z, Zhang B, Wang Z, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2024 Mar;
56(4):621-633.
PMID: 38516704
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with a global prevalence of 25%. Patients with NAFLD are more likely to suffer from advanced liver disease,...
2.
Liu Y, Jiang L, Song W, Wang C, Yu S, Qiao J, et al.
Front Cell Dev Biol
. 2023 Jul;
11:1190266.
PMID: 37476154
Recent studies have demonstrated that stem cells have attracted much attention due to their special abilities of proliferation, differentiation and self-renewal, and are of great significance in regenerative medicine and...
3.
Zhang P, Feng B, Dai G, Niu K, Zhang L
Biochem Genet
. 2023 Jun;
62(1):176-192.
PMID: 37306827
Bone defects have remained a clinical problem in current orthopedics. Bone marrow mesenchymal stem cells (BM-MSCs) with multi-directional differentiation ability have become a research hotspot for repairing bone defects. In...
4.
Qiao J, Wang C, Chen Y, Yu S, Liu Y, Yu S, et al.
Antioxidants (Basel)
. 2023 Apr;
12(4).
PMID: 37107295
Aging is a complex process of impaired physiological integrity and function, and is associated with increased risk of cardiovascular disease, diabetes, neurodegeneration, and cancer. The cellular environment of the aging...
5.
Yang Y, Zhang Y, Cao J, Su Z, Li F, Zhang P, et al.
J Exp Clin Cancer Res
. 2023 Apr;
42(1):96.
PMID: 37085881
Background: Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide, but current treatment options remain limited and cause serious life-threatening side effects. Aberrant FGFR4 signaling has...
6.
Wang S, Qiao J, Jiang C, Pan D, Yu S, Chen J, et al.
Antioxidants (Basel)
. 2023 Feb;
12(2).
PMID: 36829855
Ginsenosides, active substances in C. A. Meyer (ginseng), extend lifespan in multiple species, ameliorate age-associated damage, and limit functional decline in multiple tissues. However, their active components and their molecular...
7.
Cao J, Zhang Y, Yang Y, Xie J, Su Z, Li F, et al.
J Nanobiotechnology
. 2023 Feb;
21(1):57.
PMID: 36803772
Background: Globally, millions of patients suffer from regenerative deficiencies, such as refractory wound healing, which is characterized by excessive inflammation and abnormal angiogenesis. Growth factors and stem cells are currently...
8.
Zhang Y, He L, Yang Y, Cao J, Su Z, Zhang B, et al.
J Hazard Mater
. 2023 Jan;
447:130747.
PMID: 36680903
Triclocarban (TCC) is a widely used environmental endocrine-disrupting chemical (EDC). Articular injury of EDCs has been reported; however, whether and how TCCs damage the joint have not yet been determined....
9.
Liu Y, Wang X, Qiao J, Wang J, Jiang L, Wang C, et al.
Molecules
. 2022 Nov;
27(22).
PMID: 36431966
Cervical cancer is a common gynecological malignancy afflicting women all over the world. Ginsenoside Rh2 (GRh2), especially 20(S)-GRh2, is a biologically active component in the natural plant ginseng, which can...
10.
Niu K, Dai G, Jiang W, Zhang I, Zhang P, Tan Y, et al.
Handchir Mikrochir Plast Chir
. 2022 Jun;
54(2):E1.
PMID: 35675836
No abstract available.